PORT THERAPEUTICS
Live / Applied — Second extension granted (statement of use) (as of 30 Dec 2025)
What this means for you
Not registered yet, but its 19 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97418143
- Mark type
- Stylized text
- Filed
- 19 May 2022
- Published for opposition
- 19 Nov 2024
- Attorney of record
- Brendan J. Hughes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use, namely, pharmaceuticals for the treatment of cancer, autoimmune diseases and disorders, and ophthalmological diseases and disorders; pharmaceutical preparations for human use, namely, thermally controlled cell therapies and gene therapies
Owner
- Port Therapeutics, Inc., Los Angeles, CA, US
- Port Therapeutics, Inc., Los Angeles, CA, US
Prosecution history
- 31 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Dec 2025 — SOU EXTENSION 2 GRANTED
- 30 Dec 2025 — SOU EXTENSION 2 FILED
- 30 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jun 2025 — SOU EXTENSION 1 GRANTED
- 30 Jun 2025 — SOU EXTENSION 1 FILED
- 30 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Nov 2024 — PUBLISHED FOR OPPOSITION
- 13 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Aug 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE